Cargando…

Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice

[Image: see text] P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) are two ATP-binding cassette efflux transporters that are coexpressed at the human blood–brain barrier (BBB) and blood–retina barrier (BRB). While pharmacological inhibition of P-gp and/or BCRP results in increased b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biali, Myriam El, Auvity, Sylvain, Cisternino, Salvatore, Smirnova, Maria, Hacker, Marcus, Zeitlinger, Markus, Mairinger, Severin, Tournier, Nicolas, Bauer, Martin, Langer, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630959/ https://www.ncbi.nlm.nih.gov/pubmed/37883694 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00715

Ejemplares similares

ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
por: El Biali, Myriam, et al.
Publicado: (2021)

Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
por: Amor, Dorra, et al.
Publicado: (2018)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

Comparison of fully-automated radiosyntheses of [(11)C]erlotinib for preclinical and clinical use starting from in target produced [(11)C]CO(2) or [(11)C]CH(4)
por: Philippe, Cécile, et al.
Publicado: (2018)

Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide
por: Caillé, Fabien, et al.
Publicado: (2018)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [(11)C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
por: Breuil, Louise, et al.
Publicado: (2022)

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
por: Bauer, Martin, et al.
Publicado: (2017)

Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015)

Acute Morphine Exposure Increases the Brain Distribution of [(18)F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates
por: Auvity, Sylvain, et al.
Publicado: (2016)

A Rapid Stability-Indicating RP-HPLC Method for the Determination of Betaxolol Hydrochloride in Pharmaceutical Tablets
por: Auvity, Sylvain, et al.
Publicado: (2013)

[(11)C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans
por: Bauer, Martin, et al.
Publicado: (2011)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Imaging P‐Glycoprotein Function at the Blood–Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs
por: Bauer, Martin, et al.
Publicado: (2019)

TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model
por: Chevaleyre, Céline, et al.
Publicado: (2022)

Stability and Formulation of Erlotinib in Skin Creams
por: Nguyen, David, et al.
Publicado: (2022)

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
por: Bauer, Martin, et al.
Publicado: (2010)

Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects
por: Bauer, Martin, et al.
Publicado: (2020)

Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015)

Small-animal PET evaluation of [(11)C]MC113 as a PET tracer for P-glycoprotein
por: Mairinger, Severin, et al.
Publicado: (2010)

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
por: Bauer, Martin, et al.
Publicado: (2020)

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
por: Hernández Lozano, Irene, et al.
Publicado: (2019)

In vivo P-glycoprotein function before and after epilepsy surgery
por: Bauer, Martin, et al.
Publicado: (2014)

Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [(11)C]Metoclopramide in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease
por: Querin, Benjamin, et al.
Publicado: (2023)

Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
por: König, Lisa, et al.
Publicado: (2019)

Imaging-Based Characterization of a Slco2b1((-/-)) Mouse Model Using [(11)C]Erlotinib and [(99m)Tc]Mebrofenin as Probe Substrates
por: Marie, Solène, et al.
Publicado: (2021)

Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008)

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography
por: Wulkersdorfer, Beatrix, et al.
Publicado: (2019)

A major role for CD4(+) T cells in driving cytokine release syndrome during CAR T cell therapy
por: Boulch, Morgane, et al.
Publicado: (2023)

Specific glycoprotein changes during development of the chick neural retina
Publicado: (1978)

Classification and dissimilarity analysis
por: Cutsem, Bernard
Publicado: (1994)

Cannabinoids and COVID-19
por: El Biali, Myriam, et al.
Publicado: (2020)

Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
por: Wanek, Thomas, et al.
Publicado: (2020)

Quantification of network structural dissimilarities
por: Schieber, Tiago A., et al.
Publicado: (2017)

Dissimilarity Based Choquet Integrals
por: Bustince, Humberto, et al.
Publicado: (2020)

Characterizing dissimilarity of weighted networks
por: Jiang, Yuanxiang, et al.
Publicado: (2021)

Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice
por: Wölfl-Duchek, Michael, et al.
Publicado: (2022)

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
por: Matzneller, Peter, et al.
Publicado: (2018)

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[(11)C]Methylpurine in Mice
por: Zoufal, Viktoria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oqt0vmt8nulvnnvqhkp0ujjhql